Suppression of IκBα increases the expression of matrix metalloproteinase-2 in human ciliary muscle cells

Molecular Vision

Volumn 15, Issue , 2009, Pages 1977-1987

  Lan, Yu Qing ^a   Zhang, Chi ^a   Xiao, Jian Hui ^a   Zhuo, Ye Hong ^b   Guo, Hui ^a   Peng, Wei ^a   Ge, Jian ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; I KAPPA B KINASE ALPHA; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR RELA; I KAPPA B; MMP14 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ARTICLE; CILIARY MUSCLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME RELEASE; GENE FUNCTION; HUMAN; HUMAN CELL; MUSCLE CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL CULTURE; CELL NUCLEUS; CILIARY BODY; CYTOLOGY; ENZYMOLOGY; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; PROTEIN TRANSPORT;

CELL NUCLEUS; CELLS, CULTURED; CILIARY BODY; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; I-KAPPA B PROTEINS; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MUSCLE CELLS; PROTEIN TRANSPORT; RNA, MESSENGER; RNA, SMALL INTERFERING; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 70349694015     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bito LZ. Prostaglandins: a new approach to glaucoma management with a new, intriguing side effect. Surv Ophthalmol 1997; 41:S1-14.
2. Bito LZ, Stjernschantz J, Resul B, Miranda OC, Basu S. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41(latanoprost), for glaucoma management. J Lipid Mediat 1993; 6:535-43.
3. Poyer JF, Millar C, Kaufman PL. Prostaglandin F2 alpha effects on isolated rhesus monkey ciliary muscle. Invest Ophthalmol Vis Sci 1995; 36:2461-5.
4. Weinreb RN, Toris CB, Gabelt BT, Lindsey JD, Kaufman PL. Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol 2002; 47:S53-64.
5. Lütjen-Drecoll E, Tamm E. Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2 alpha. Exp Eye Res 1988; 47:761-9.
6. Vanalphen GW, Kern R, Robinette SL. Adrenergic receptors of the intraocular muscles: comparison to cat, rabbit and monkey. Arch Ophthalmol 1965; 74:253-9.
7. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4:197-250.
8. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissueremodeling. FASEB J 1991; 5:2145-54.
9. Baramova E, Foidart JM. Matrix rnetalloproteinase family. Cell Biol Int 1995; 19:239-42.
10. Strongin AY, Collier J, Bannikov G, Marmer BL, Grant GA, Golberg GI. Mechanism of cell surface activation of 72 kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995; 270:5331-8.
11. Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, Raz Y, Seng QA, Fridman R. Binding of active (57 kDa) membrane type1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulatesMT1-MMPprocessing and pro-MMP-2 activation. J Biol Chem 2000; 275:12080-9.
12. Tamm E, Lutjen-Drecoll E, Rohen JW. Age-related changes of the ciliary muscle in comparison with changes induced by treatment with prostaglandin F2α. An ultrastructural study in rhesus and cynomolgus monkeys. Mech Ageing Dev 1990; 51:101-20.
13. Marshall GE, Konstas AG, Abraham S, Lee WR. Extracellular matrix in aged human ciliary body: An immunoelectron microscope study. Invest Ophthalmol Vis Sci 1992; 33:2546-60.
14. Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow. Surv Ophthalmol 1997; 41:s53-9.
15. Ghosh S, May MJ, Kopp EB. NF-kappa B, Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16:225-60.
16. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12:141-79.
17. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996; 87:13-20.
18. Henkel T, Zabel U, Van Zee K, Muller JM, Fanning E, Baeuerle PA. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit. Cell 1992; 68:1121-33.
19. Baeuerle PA, Baichwal VR. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 1997; 65:111-36.
20. Javelaud D, Poupon MF, Wietzerbin J, Besancon F. Inhibition of constitutive NF-kappa B activity suppresses tumorigenicity of Ewing sarcoma EW7 cells. Int J Cancer 2002; 98:193-8.
21. Han YP, Tuan TL, Wu H, Hughes M, Garner WL. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci 2001; 114:131-9.
22. Philip S, Bulbule A, Kundu GC. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediates induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem 2001; 276:44926-35.
23. Park JM, Kim A, Oh JH, Chung AS. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kB activation. Carcinogenesis 2007; 28:837-47.
24. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277:925-6.
25. Husain S, Kaddour-Djebbar I, Abdel-Latif AA. Alterations in arachidonic acid release and phospholipase C-beta(1) expression in glaucomatous human ciliary muscle cells. Invest Ophthalmol Vis Sci 2002; 43:1127-34.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8.
27. Weinreb RN, Kim DM, Lindsey JD. Propagation of ciliary smooth muscle cells in vitro and effects of prostaglandin F2α on calcium efflux. Invest Ophthalmol Vis Sci 1992; 33:2679-86.
28. Tamm E, Flugel C, Baur A, Lutjen-Drecoll E. Cell cultures of human ciliary muscle: Growth, ultrastructural and immunocytochemical characteristics. Exp Eye Res 1991; 53:375-87.
29. Pomerantz JL, Baltimore D. Two pathways to NF-kappaB. Mol Cell 2002; 10:693-5.
30. Kim H, Koh G. Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kB-dependent pathway. Biochem Biophys Res Commun 2000; 269:401-5.
31. Lindsey JD, To HD, Weinreb RN. Induction of c-Fos by Prostaglandin F2α in Human Ciliary Smooth Muscle Cells. Invest Ophthalmol Vis Sci 1994; 35:242-50.
32. Stein B, Baldwin AS Jr, Ballard DW, Warner C, Greene AP, Herrlich P. Cross-coupling of the NF-kappa B p65 and Fos/ Jun transcription factors produces potentiated biological function. EMBO J 1993; 12:3879-91.
33. Grimm S, Bauer MKA, Baeuerle PA, Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J Cell Biol 1996; 134:13-23.
34. Jung M, Zhang Y, Lee S, Dritschilo A. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IκBα. Science 1995; 268:1619-21.
35. Kasibhatla S, Genestier L, Green DR. Regulation of Fas-Ligand expression during activation-induced cell Death in T lymphocytes via Nuclear Factor κB. J Biol Chem 1999; 274:987-92.